Big Money Sentiment decreased to 0.94 in 2018 Q4. It has change of 0.69, from 2018Q3’s 1.63. The ratio fall due to Acadia Healthcare Company, Inc. positioning: 29 sold and 80 reduced. 38 funds bought stakes and 64 increased stakes. Investors holded 102.30 million in 2018Q3 but now own 99.01 million shares or 3.22% less.
Prudential Fincl Inc stated it has 0.02% of its capital in Acadia Healthcare Company, Inc. (NASDAQ:ACHC). 508,562 were accumulated by Waddell Reed. Palisade Limited Liability Nj accumulated 463,544 shs. Kentucky-based Teachers Retirement Sys Of The State Of Kentucky has invested 0% in Acadia Healthcare Company, Inc. (NASDAQ:ACHC). Principal Financial Gp Inc invested in 0.01% or 379,695 shs. Us Bancorporation De stated it has 0% in Acadia Healthcare Company, Inc. (NASDAQ:ACHC). Ameriprise accumulated 675,856 shs. 20,000 are held by Nj State Employees Deferred Compensation Plan. Tiaa Cref Management Limited Company holds 259,212 shs. The Illinois-based Citadel Advsrs Limited Liability has invested 0.02% in Acadia Healthcare Company, Inc. (NASDAQ:ACHC). State Board Of Administration Of Florida Retirement System invested 0.01% of its capital in Acadia Healthcare Company, Inc. (NASDAQ:ACHC). California State Teachers Retirement Systems holds 0.01% in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) or 229,879 shs. 16 were reported by Parkside Finance Bank & Trust And Tru. Congress Asset Management Ma, Massachusetts-based fund reported 169,593 shs. Alabama-based Regions Fin has invested 0% in Acadia Healthcare Company, Inc. (NASDAQ:ACHC).

Acadia Healthcare Company, Inc. had 1 insider sale and 0 buys since November 1, 2018. This’s net activity of $1.88 million.

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Ratings Coverage

In total 7 analysts cover Acadia Healthcare Co (NASDAQ:ACHC). “Buy” rating has 3, “Sell” are 0, while 4 are “Hold”. 43% are bullish. 10 are the (NASDAQ:ACHC)’s analyst reports since November 14, 2018 according to StockzIntelligence Inc. On Monday, March 4 the stock of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) earned “Buy” rating by Citigroup. On Monday, March 4 the firm has “Neutral” rating by Robert W. Baird given. On Monday, March 4 the stock of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) has “Buy” rating given by Raymond James. On Monday, March 4 the firm has “Hold” rating by Credit Suisse given. In Monday, March 4 report RBC Capital Markets maintained the stock with “Buy” rating. On Wednesday, November 14 Citigroup maintained Acadia Healthcare Company, Inc. (NASDAQ:ACHC) with “Buy” rating. In Tuesday, March 5 report BMO Capital Markets maintained the stock with “Hold” rating. On Friday, March 1 Robert W. Baird maintained the shares of ACHC in report with “Hold” rating. Listed here are Acadia Healthcare Company, Inc. (NASDAQ:ACHC) PTs and latest ratings.

05/03/2019 Broker: BMO Capital Markets Rating: Hold New Target: $33 Maintain
04/03/2019 Broker: RBC Capital Markets Rating: Buy New Target: $42 Maintain
04/03/2019 Broker: Raymond James Rating: Buy New Target: $40 Maintain
04/03/2019 Broker: Credit Suisse Rating: Hold New Target: $33 Maintain
04/03/2019 Broker: Leerink Swann Rating: Hold Maintain
04/03/2019 Broker: Robert W. Baird Old Rating: Neutral New Rating: Neutral Old Target: $40 New Target: $38 Maintain
04/03/2019 Broker: Citigroup Old Rating: Buy New Rating: Buy Old Target: $43 New Target: $38 Maintain
01/03/2019 Broker: Robert W. Baird Rating: Hold New Target: $38 Maintain
03/01/2019 Broker: Deutsche Bank Rating: Hold New Target: $27 Initiates Coverage On
14/11/2018 Broker: Citigroup Old Rating: Buy New Rating: Buy Old Target: $46 New Target: $43 Maintain

ACHC touched $28.25 during the last trading session after $1.04 change.Acadia Healthcare Company, Inc. is downtrending after having declined 20.29% since March 7, 2018. ACHC has 1.90M volume or 44.25% up from normal. The stock underperformed the S&P500 by 24.66%.

Acadia Healthcare Company, Inc. develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States, the United Kingdom, and Puerto Rico.The firm is worth $2.49 billion. The companyÂ’s acute inpatient psychiatric facilities offer evaluation and crisis stabilization of patients with severe psychiatric diagnoses; specialty treatment facilities include residential recovery facilities, eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders; and residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs.Last it reported negative earnings. It also provides outpatient community services, such as community programs that are designed to provide therapeutic treatment to children and adolescents who have a clinically-defined emotional, psychiatric, or chemical dependency disorder.

For more Acadia Healthcare Company, Inc. (NASDAQ:ACHC) news brought out recently go to: Seekingalpha.com, Nasdaq.com, Seekingalpha.com, Seekingalpha.com or Fool.com. The titles are as follows: “Video Breakdown Gives Skewed Viewpoint For Future Of Acadia Healthcare – Seeking Alpha” brought out on January 04, 2019, “Moody’s Downgrades Acadia’s (ACHC) Outlook, Affirms Ratings – Nasdaq” on December 11, 2018, “On Separate Sides Of The World, Acadia Healthcare Runs Into Expansion Problems – Seeking Alpha” with a publish date: February 06, 2019, “NY Post: KKR deal for Acacia Healthcare still plugged in – Seeking Alpha” and the last “Acadia Healthcare (ACHC) Q4 2018 Earnings Conference Call Transcript – Motley Fool” with publication date: March 02, 2019.